AlphaStocks
5.7
Consider Buy

Henry Schein Inc (HSIC)

As of Sep 20, 2026, Henry Schein Inc (HSIC) scores 5.7/10 on AlphaStocks' five-model composite, #66 of 168 Health Care stocks. At $85, HSIC trades 1% below its model fair value of $86.

Health Care / Health Care Distributors

S&P 500

$84.81

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#66out of 168 in Health Care

Is HENRY SCHEIN INC a Good Investment in 2026?

HENRY SCHEIN INC (HSIC) scores 5.7 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Buffett model rates HENRY SCHEIN INC as Attractive. However, the Graham model rates it Caution — 86% above fair value. HENRY SCHEIN INC currently trades 1% below its estimated fair value of $86. HENRY SCHEIN INC ranks #66 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E24.6ROE12.7Market Cap10B

Estimated Fair Value

$85.511% below

Trading near estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

86% above fair value

Lynch

Neutral

High PEG — growth premium · Slow Grower

Greenblatt

Attractive

Earnings yield 8.8% · ROC 19%

Frequently Asked Questions

Is HENRY SCHEIN INC (HSIC) a good investment?
As of Sep 20, 2026, Henry Schein Inc (HSIC) scores 5.7/10 on AlphaStocks' five-model composite, #66 of 168 Health Care stocks. At $85, HSIC trades 1% below its model fair value of $86. That is a middle-of-the-pack score with no strong signal either way.
What is HENRY SCHEIN INC's Piotroski F-Score?
HENRY SCHEIN INC's Piotroski F-Score status is Neutral. The raw score is 4/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is HSIC overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $86, HSIC appears undervalued. The stock currently trades 1% below its estimated fair value. Trading near estimated fair value.
How does HSIC compare to other Health Care stocks?
HENRY SCHEIN INC ranks #66 out of 168 stocks in the Health Care sector, placing it in the top 39% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about HSIC?
AlphaStocks evaluates HSIC using five proven investment models. Piotroski: Neutral; Buffett: Attractive; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 5.7/10.

Similar Stocks

CAHMCKCOR

Compare HSIC with

CAH vs HSICHSIC vs MCKCOR vs HSICHSIC vs PARRHSIC vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer